Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact

Abstract

LH is common in China and associated with worse glycemic control, despite nearly one-third greater insulin consumption, with large cost implications. Proper injection technique education may reduce LH prevalence.